179 related articles for article (PubMed ID: 8936631)
1. Androgen therapy for anaemia of chronic renal failure. Indications in the erythropoietin era.
Teruel JL; Aguilera A; Marcen R; Navarro Antolin J; Garcia Otero G; Ortuño J
Scand J Urol Nephrol; 1996 Oct; 30(5):403-8. PubMed ID: 8936631
[TBL] [Abstract][Full Text] [Related]
2. Androgens for the anaemia of chronic kidney disease in adults.
Yang Q; Abudou M; Xie XS; Wu T
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD006881. PubMed ID: 25300168
[TBL] [Abstract][Full Text] [Related]
3. A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients.
Gaughan WJ; Liss KA; Dunn SR; Mangold AM; Buhsmer JP; Michael B; Burke JF
Am J Kidney Dis; 1997 Oct; 30(4):495-500. PubMed ID: 9328363
[TBL] [Abstract][Full Text] [Related]
4. Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study.
Teruel JL; Marcen R; Navarro-Antolin J; Aguilera A; Fernandez-Juarez G; Ortuño J
J Am Soc Nephrol; 1996 Jan; 7(1):140-4. PubMed ID: 8808121
[TBL] [Abstract][Full Text] [Related]
5. Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease.
Ballal SH; Domoto DT; Polack DC; Marciulonis P; Martin KJ
Am J Kidney Dis; 1991 Jan; 17(1):29-33. PubMed ID: 1986567
[TBL] [Abstract][Full Text] [Related]
6. Androgens for the treatment of anemia in peritoneal dialysis patients.
Navarro JF; Mora-Fernández C; Rivero A; Macía M; Gallego E; Chahin J; Méndez ML; García J
Adv Perit Dial; 1998; 14():232-5. PubMed ID: 10649731
[TBL] [Abstract][Full Text] [Related]
7. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
Navarro JF; Mora C; Macía M; García J
Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
[TBL] [Abstract][Full Text] [Related]
8. Androgen versus erythropoietin for the treatment of anaemia of pre-dialysis chronic kidney disease.
Paul AK; Latif ZA; Iqbal S; Amin F; Shefin SM; Ashrafuzzaman SM
Mymensingh Med J; 2012 Jan; 21(1):125-8. PubMed ID: 22314467
[TBL] [Abstract][Full Text] [Related]
9. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis.
Berns JS; Rudnick MR; Cohen RM
Clin Nephrol; 1992 May; 37(5):264-7. PubMed ID: 1606777
[TBL] [Abstract][Full Text] [Related]
10. Evolution of serum erythropoietin after androgen administration to hemodialysis patients: a prospective study.
Teruel JL; Marcén R; Navarro JF; Villafruela JJ; Fernández Lucas M; Liaño F; Ortuño J
Nephron; 1995; 70(3):282-6. PubMed ID: 7477614
[TBL] [Abstract][Full Text] [Related]
11. Nandrolone decanoate reduces serum lipoprotein(a) concentrations in hemodialysis patients.
Teruel JL; Lasuncion MA; Rivera M; Aguilera A; Ortega H; Tato A; Marcen R; Ortuño J
Am J Kidney Dis; 1997 Apr; 29(4):569-75. PubMed ID: 9100047
[TBL] [Abstract][Full Text] [Related]
12. The effects of nandrolone decanoate on nutritional parameters in hemodialysis patients.
Barton Pai A; Chretien C; Lau AH
Clin Nephrol; 2002 Jul; 58(1):38-46. PubMed ID: 12141405
[TBL] [Abstract][Full Text] [Related]
13. Androgen trial in renal anaemia.
Naik RB; Gibbons AR; Gyde OH; Harris BR; Robinson BH
Proc Eur Dial Transplant Assoc; 1978; 15():136-43. PubMed ID: 368770
[TBL] [Abstract][Full Text] [Related]
14. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.
BMJ; 1990 Mar; 300(6724):573-8. PubMed ID: 2108751
[TBL] [Abstract][Full Text] [Related]
15. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.
Winearls CG; Oliver DO; Pippard MJ; Reid C; Downing MR; Cotes PM
Lancet; 1986 Nov; 2(8517):1175-8. PubMed ID: 2877323
[TBL] [Abstract][Full Text] [Related]
16. A study of recombinant human erythropoietin in the treatment of anaemia of chronic renal failure in children on haemodialysis.
Van Damme-Lombaerts R; Broyer M; Businger J; Baldauf C; Stocker H
Pediatr Nephrol; 1994 Jun; 8(3):338-42. PubMed ID: 7917862
[TBL] [Abstract][Full Text] [Related]
17. Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis.
Gascón A; Belvis JJ; Berisa F; Iglesias E; Estopiñán V; Teruel JL
Geriatr Nephrol Urol; 1999; 9(2):67-72. PubMed ID: 10518249
[TBL] [Abstract][Full Text] [Related]
18. Effects of adjuvant androgen on anemia and nutritional parameters in chronic hemodialysis patients using low-dose recombinant human erythropoietin.
Lee MS; Ahn SH; Song JH
Korean J Intern Med; 2002 Sep; 17(3):167-73. PubMed ID: 12298427
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
[TBL] [Abstract][Full Text] [Related]
20. Androgen therapy in haemodialysis patients. II. Effects on red cell metabolism.
Solomon LR; Hendler ED
Br J Haematol; 1987 Feb; 65(2):223-30. PubMed ID: 3828230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]